Tailoring pathway modularity in the biosynthesis of erythromycin analogs heterologously engineered in E. coli

Science Advances

Volumn 1, Issue 4, 2015, Pages

  Zhang, Guojian ^a   Li, Yi ^a   Fang, Lei ^a   Pfeifer, Blaine A ^a  

^a State University of New York   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOLOGY; BIOCHEMISTRY; BIOSYNTHESIS; ESCHERICHIA COLI; KETONES; SUGARS;

AVERMECTINS; BACILLUS SUBTILIS STRAINS; HETEROLOGOUS SYSTEMS; MOLECULAR VARIATION; NATURAL PRODUCTS; POLYKETIDE SYNTHASES; POLYKETIDES; THERAPEUTIC COMPOUNDS;

ANTIBIOTICS;

EID: 84977944118     PISSN: None     EISSN: 23752548     Source Type: Journal    
DOI: 10.1126/sciadv.1500077     Document Type: Article

References (54)

1. G. M. Cragg, D. J. Newman, Natural products: A continuing source of novel drug leads. Biochim. Biophys. Acta 1830, 3670-3695 (2013).
2. D. J. Newman, G. M. Cragg, Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 75, 311-335 (2012).
3. A. L. Demain, From natural products discovery to commercialization: A success story.J. Ind. Microbiol. Biotechnoi. 33, 486-495 (2006).
4. A. L. Demain, S. Sanchez, Microbial drug discovery: 80 years of progress. J. Antibiot. 62, 5-16 (2009) .
5. N. Kardos, A. L. Demain, Penicillin: The medicine with the greatest impact on therapeutic outcomes. Appl. Microbiol. Biotechnoi. 92, 677-687 (2011).
6. J. Davies, K. S. Ryan, Introducing the parvome: Bioactive compounds in the microbial world. ACS Chem. Biol. 7, 252-259 (2012).
7. H. Zhang, B. A. Boghigian, J. Armando, B. A. Pfeifer, Methods and options for the heterologous production of complex natural products. Nat. Prod. Rep. 28, 125-151 (2011).
8. S. E. Ongley, X. Bian, B. A. Neilan, R. Muller, Recent advances in the heterologous expression of microbial natural product biosynthetic pathways. Nat. Prod. Rep. 30, 1121-1138 (2013).
9. K. J. Weissman, P. F. Leadlay, Combinatorial biosynthesis of reduced polyketides. Nat. Rev. Microbiol. 3, 925-936 (2005).
10. C. Khosla, P. B. Harbury, Modular enzymes. Nature 409, 247-252 (2001).
11. S. Donadio, M. J. Staver, J. B. McAlpine, S. J. Swanson, L. Katz, Modular organization of genes required for complex polyketide biosynthesis. Science 252, 675-679 (1991).
12. J. Cortes, S. F. Haydock, G. A. Roberts, D. J. Bevitt, P. F. Leadlay, An unusually large multifunctional polypeptide in the erythromycin-producing polyketide synthase of Saccharopo-lyspora erythraea. Nature 348, 176-178 (1990).
13. R. G. Summers, S. Donadio, M. J. Staver, E. Wendt-Pienkowski, C. R. Hutchinson, L. Katz, Sequencing and mutagenesis of genes from the erythromycin biosynthetic gene cluster of Saccharopolyspora erythraea that are involved in L-mycarose and D-desosamine production. Microbiology 143, 3251-3262 (1997).
14. K. Salah-Bey, M. Doumith, J. M. Michel, S. Haydock, J. Cortes, P. F. Leadlay, M. C. Raynal, Targeted gene inactivation for the elucidation of deoxysugar biosynthesis in the erythromycin producer Saccharopolyspora erythraea. Mol. Gen. Genet. 257, 542-553 (1998).
15. B. A. Pfeifer, S. J. Admiraal, H. Gramajo, D. E. Cane, C. Khosla, Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science 291, 1790-1792 (2001).
16. H. Zhang, Y. Wang, J. Wu, K. Skalina, B. A. Pfeifer, Complete biosynthesis of erythromycin A and designed analogs using E. coli as a heterologous host. Chem. Biol. 17, 1232-1240 (2010) .
17. C. Khosla, Harnessing the biosynthetic potential of modular polyketide synthases. Chem. Rev. 97, 2577-2590 (1997).
18. A. C. Weymouth-Wilson, The role of carbohydrates in biologically active natural products. Nat. Prod. Rep. 14, 99-110 (1997).
19. J. S. Thorson, T. J. Hosted Jr., J. Jiang, J. B. Biggins, J. Ahlert, Natures carbohydrate chemists the enzymatic glycosylation of bioactive bacterial metabolites. Curr. Org. Chem. 5,139-167 (2001) .
20. U. Rix, C. Fischer, L. L. Remsing, J. Rohr, Modification of post-PKS tailoring steps through combinatorial biosynthesis. Nat. Prod. Rep. 19, 542-580 (2002).
21. C. Olano, C. Mendez, J. A. Salas, Post-PKS tailoring steps in natural product-producing actino-mycetes from the perspective of combinatorial biosynthesis. Nat. Prod. Rep. 27, 571-616 (2010).
22. F. Lombo, K. Siems, A. F. Braha, C. Mendez, K. Bindseil, J. A. Salas, Cloning and insertional inactivation of Streptomyces argillaceus genes involved in the earliest steps of biosynthesis of the sugar moieties of the antitumor polyketide mithramycin. J. Bacteriol. 179, 3354-3357 (1997).
23. M. Jiang, H. Zhang, S. H. Park, Y. Li, B. A. Pfeifer, Deoxysugar pathway interchange for erythromycin analogues heterologously produced through Escherichia coli. Metab. Eng. 20, 92-100 (2013).
24. L. Rodriguez, I. Aguirrezabalaga, N. Allende, A. F. Braha, C. Mendez, J. A. Salas, Engineering deoxysugar biosynthetic pathways from antibiotic-producing microorganisms. A tool to produce novel glycosylated bioactive compounds. Chem. Biol. 9, 721-729 (2002) .
25. M. Perez, I. Baig, A. F. Braha, J. A. Salas, J. Rohr, C. Mendez, Generation of new derivatives of the antitumor antibiotic mithramycin by altering the glycosylation pattern through combinatorial biosynthesis. Chembiochem 9, 2295-2304 (2008).
26. M. D. Shepherd, T. Liu, C. Mendez, J. A. Salas, J. Rohr, Engineered biosynthesis of gilvocarcin analogues with altered deoxyhexopyranose moieties. Appl. Environ. Microbiol. 77, 435-441 (2011) .
27. F. Lombo, M. Gibson, L. Greenwell, A. F. Braha, J. Rohr, J. A. Salas, C. Mendez, Engineering biosynthetic pathways for deoxysugars: Branched-chain sugar pathways and derivatives from the antitumor tetracenomycin. Chem. Biol. 11, 1709-1718 (2004).
28. A. R. Han, J. W. Park, M. K. Lee, Y. H. Ban, Y. J. Yoo, E. J. Kim, E. Kim, B. G. Kim, J. K. Sohng, Y. J. Yoon, Development of a Streptomyces venezuelae-based combinatorial biosynthetic system for the production of glycosylated derivatives of doxorubicin and its biosynthetic intermediates. Appl. Environ. Microbiol. 77, 4912-4923 (2011).
29. A. R. Han, S. R. Park, J. W. Park, E. Y. Lee, D. M. Kim, B. G. Kim, Y. J. Yoon, Biosynthesis of glycosylated derivatives of tylosin in Streptomyces venezuelae. J. Microbiol. Biotechnoi. 21, 613-616 (2011).
30. A. R. Han, P. B. Shinde, J. W. Park, J. Cho, S. R. Lee, Y. H. Ban, Y. J. Yoo, E. J. Kim, E. Kim, S. R. Park, B. G. Kim, D. G. Lee, Y. J. Yoon, Engineered biosynthesis of glycosylated derivatives of narbo-mycin and evaluation of their antibacterial activities. Appl. Microbiol. Biotechnoi. 93,1147-1156 (2012) .
31. J. S. Hong, S. H. Park, C Y. Choi, J. K. Sohng, Y.J. Yoon, Newolivosyl derivatives of methymycin/ pikromycin from an engineered strain of Streptomyces venezuelae. FEMS Microbiol. Lett. 238, 391-399 (2004).
32. G. Blanco, E. P. Patallo, A. F. Braha, A. Trefzer, A. Bechthold, J. Rohr, C. Mendez, J. A. Salas, Identification of a sugar flexible glycosyltransferase from Streptomyces oiivaceus, the producer of the antitumor polyketide elloramycin. Chem. Biol. 8, 253-263 (2001).
33. U. Schell, S. F. Haydock, A. L. Kaja, I. Carletti, R. E. Lill, E. Read, L. S. Sheehan, L. Low, M. J. Fernandez, F. Grolle, H. A. McArthur, R. M. Sheridan, P. F. Leadlay, B. Wilkinson, S. Gaisser, Engineered biosynthesis of hybrid macrolide polyketides containing D-angolosamine and D-mycaminose moieties. Org. Biomol. Chem. 6, 3315-3327 (2008).
34. M. Perez, F. Lombo, I. Baig, A. F. Braha, J. Rohr, J. A. Salas, C. Mendez, Combinatorial biosynthesis of antitumor deoxysugar pathways in Streptomyces griseus: Reconstitution of "unnatural natural gene clusters" for the biosynthesis of four 2,6-D-dideoxyhexoses. Appl. Environ. Microbiol. 72, 6644-6652 (2006).
35. C. E. Melancon III, H. W. Liu, Engineered biosynthesis of macrolide derivatives bearing the non-natural deoxysugars 4-ep/-r>mycaminose and 3-A/-monomethylamino-3-deoxy-D-fucose. J. Am. Chem. Soc. 129, 4896-4897 (2007).
36. C. E. Melancon III, W. L. Yu, H. W. Liu, TDP-mycaminose biosynthetic pathway revised and conversion of desosamine pathway to mycaminose pathway with one gene. J. Am. Chem. Soc. 127, 12240-12241 (2005).
37. R. H. Lambalot, D. E. Cane, J. J. Aparicio, L. Katz, Overproduction and characterization of the erythromycin C-12 hydroxylase, EryK. Biochemistry 34, 1858-1866 (1995).
38. T.J. Paulus, J. S.Tuan, V. E. Luebke, G.T. Maine, J. P. DeWitt, L. Katz, Mutation and cloning of eryG, the structural gene for erythromycin O-methyltransferase from Saccharopolyspora erythraea, and expression of eryG in Escherichia coli. J. Bacteriol. 172, 2541-2546 (1990).
39. I. Aguirrezabalaga, C. Olano, N. Allende, L. Rodriguez, A. F. Braha, C. Mendez, J. A. Salas, Identification and expression of genes involved in biosynthesis of L-oleandrose and its intermediate L-olivose in the oleandomycin producer Streptomyces antibioticus. Antimicrob. Agents Chemother. 44, 1266-1275 (2000).
40. A. Gonzalez, L. L. Remsing, F. Lombo, M. J. Fernandez, L. Prado, A. F. Braha, E. Kunzel, J. Rohr, C. Mendez, J. A. Salas, The mtmVUC genes of the mithramycin gene cluster in Streptomyces argillaceus are involved in the biosynthesis of the sugar moieties. Mol. Gen. Genet. 264, 827-835 (2001).
41. G. Wang, M. K. Kharel, P. Pahari, J. Rohr, Investigating mithramycin deoxysugar biosynthesis: Enzymatic total synthesis of TDP-D-olivose. Chembiochem 12, 2568-2571 (2011).
42. G. Wang, P. Pahari, M. K. Kharel, J. Chen, H. Zhu, S. G. Van Lanen, J. Rohr, Cooperation of two bifunctional enzymes in the biosynthesis and attachment of deoxysugars of the antitumor antibiotic mithramycin. Angew. Chem. Int. Ed. Engl. 51, 10638-10642 (2012).
43. D. Hoffmeister, K. Ichinose, S. Domann, B. Faust, A. Trefzer, G. Drager, A. Kirschning, C. Fischer, E. Kunzel, D. Bearden, J. Rohr, A. Bechthold, The NDP-sugar co-substrate concentration and the enzyme expression level influence the substrate specificity of glycosyltransferases: Cloning and characterization of deoxysugar biosynthetic genes of the urdamycin biosynthetic gene cluster. Chem. Biol. 7, 821-831 (2000).
44. N. Menendez, M. Nur-e-Alam, A. F. Braha, J. Rohr, J. A. Salas, C. Mendez, Biosynthesis of the antitumor chromomycin A3 in Streptomyces griseus: Analysis of the gene cluster and rational design of novel chromomycin analogs. Chem. Biol. 11, 21-32 (2004).
45. C. J. Harvey, J. D. Puglisi, V. S. Pande, D. E. Cane, C. Khosla, Precursor directed biosynthesis of an orthogonally functional erythromycin analogue: Selectivity in the ribosome macrolide binding pocket. J. Am. Chem. Soc. 134, 12259-12265 (2012).
46. H. Y. Lee, C. J. Harvey, D. E. Cane, C. Khosla, Improved precursor-directed biosynthesis in E. coli via directed evolution. J. Antibiot. 64, 59-64 (2011).
47. H. Y. Lee, C. Khosla, Bioassay-guided evolution of glycosylated macrolide antibiotics in Escherichia coli. PLOS Biol. 5, e45 (2007).
48. D. Tu, G. Blaha, P. B. Moore, T. A. Steitz, Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance. Cell 121, 257-270 (2005).
49. L. Katz, D. Brown, K. Boris, J. Tuan, Expression of the macrolide-lincosamide-streptogramin-Bresistance methylase gene, ermE, from Streptomyces erythraeus in Escherichia coli results in N6-monomethylation and N6,N6-dimethylation of ribosomal RNA. Gene 55, 319-325 (1987).
50. F. Schlünzen, J. M. Harms, F. Franceschi, H. A. Hansen, H. Bartels, R. Zarivach, A. Yonath, Structural basis for the antibiotic activity of ketolides and azalides. Structure 11, 329-338 (2003).
51. F. Schlünzen, R. Zarivach, J. Harms, A. Bashan, A. Tocilj, R. Albrecht, A. Yonath, F. Franceschi, Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413, 814-821 (2001).
52. D. Grushkin, Natural products emergent. Nat. Med. 19, 390-392 (2013).
53. M. Jiang, L. Fang, B. A. Pfeifer, Improved heterologous erythromycin a production through expression plasmid re-design. Biotechnol. Prog. 29, 862-869 (2013).
54. H. Zhang, B. A. Boghigian, B. A. Pfeifer, Investigating the role of native propionyl-CoA and methylmalonyl-CoA metabolism on heterologous polyketide production in Escherichia coli. Biotechnol. Bioeng. 105, 567-573 (2010).